Lucas Nivon
banner
lucasnivon.bsky.social
Lucas Nivon
@lucasnivon.bsky.social
CEO and co-founder at Cyrus Bio. Co-founder OpenFold AI bio consortium. Computational protein/biologic discovery. Rare disease, auto-immune, anti-viral, vax. PhD Harvard Biophys, Postdoc Bakerlab at UW. #Urbanism, #bikes, #democracy, #proteinai
So excited to read this. New ideas that are not mercantilism. Grow housing, tech, biotech, and transit! #urbanism @ezraklein.bsky.social is pointing a potent new direction
March 22, 2025 at 9:00 PM
VC/PE backed biotech is responsible for most top selling biologics. Followed by internal Big Pharma and publicly funded (NIH, MRC, etc.). My analysis of 2023 top drugs. Many of the "biotechs" listed spun out of academic publicly funded research e.g. CAT. #nih #biotech #drugdiscovery #biologics
February 17, 2025 at 9:40 PM
Foundation models in #ai will likely be open source. Not a surprise what we are seeing from Deepseek over the last weeks. It reminds me of the four minute mile. We've seen it already in #biotech medium.com/@lucas_nivon...
January 27, 2025 at 9:58 PM
Read about Cyrus Biotech's immunogenicity reduction work in novel CRISPR Cas enzymes in collaboration with
Feng Zhang lab, we continue to advance our immunogenicity #ai and #bigdata platform against new targets like CYR212 in IgG-driven autoimmune. www.msn.com/en-us/scienc...
January 10, 2025 at 1:13 AM
Cyrus co-founder Yifan Song with co-founder David Baker and other alums of @uwproteindesign.bsky.social after David’s Nobel Prize talk in protein design with #ai
December 10, 2024 at 4:20 PM